Boglarka Gyurkocza

Trials

Studies that name Boglarka Gyurkocza as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:30 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04377659 · Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

  Memorial Sloan Kettering Cancer Center · terminated · COVID-19 · principal investigator
• Ph2
  NCT00860574 · Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

  Fred Hutchinson Cancer Center · completed · Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
  P01HL036444 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI H. JOACHIM DEEG · fiscal years 1986 to 2010
  Named on NCT00860574